| cellular process (GO:0009987) | 0.26 | 15 | RYR2, SCN5A, CASQ2, LMNA, LAMA4, KCNH2, TPM1, DSG2, TRDN, ANK2, CALM1, MYBPC3, DMPK, TRPM4, DSP |
| regulation of cellular process (GO:0050794) | 0.5 | 15 | RYR2, SCN5A, CASQ2, DSG2, LAMA4, KCNH2, TPM1, TRDN, LMNA, DMPK, ANK2, CALM1, MYBPC3, TRPM4, DSP |
| single-organism cellular process (GO:0044763) | 0.65 | 15 | RYR2, SCN5A, CASQ2, LMNA, LAMA4, KCNH2, TPM1, DSG2, TRDN, ANK2, CALM1, MYBPC3, DMPK, TRPM4, DSP |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 15 | RYR2, SCN5A, CASQ2, DSG2, LAMA4, KCNH2, TPM1, TRDN, LMNA, DMPK, ANK2, CALM1, MYBPC3, TRPM4, DSP |
| biological regulation (GO:0065007) | 0.39 | 15 | RYR2, SCN5A, CASQ2, LMNA, LAMA4, KCNH2, TPM1, TRDN, DSG2, ANK2, CALM1, MYBPC3, DMPK, TRPM4, DSP |
| regulation of localization (GO:0032879) | 1.94 | 15 | RYR2, SCN5A, CASQ2, LMNA, LAMA4, KCNH2, TPM1, DSG2, TRDN, ANK2, CALM1, MYBPC3, DMPK, TRPM4, DSP |
| regulation of biological process (GO:0050789) | 0.45 | 15 | RYR2, SCN5A, CASQ2, LMNA, LAMA4, KCNH2, TPM1, TRDN, DSG2, ANK2, CALM1, MYBPC3, DMPK, TRPM4, DSP |
| single-organism process (GO:0044699) | 0.48 | 15 | RYR2, SCN5A, CASQ2, DSG2, LAMA4, KCNH2, TPM1, TRDN, LMNA, DMPK, ANK2, CALM1, MYBPC3, TRPM4, DSP |
| regulation of system process (GO:0044057) | 3.53 | 13 | RYR2, SCN5A, CASQ2, DSG2, TRPM4, KCNH2, TPM1, TRDN, DMPK, ANK2, CALM1, MYBPC3, DSP |
| multicellular organismal process (GO:0032501) | 1.45 | 12 | RYR2, SCN5A, CASQ2, TRPM4, KCNH2, TPM1, TRDN, DSG2, ANK2, CALM1, MYBPC3, DSP |
| regulation of blood circulation (GO:1903522) | 4.05 | 12 | RYR2, SCN5A, CASQ2, DSG2, TRPM4, KCNH2, TPM1, TRDN, DMPK, ANK2, CALM1, DSP |
| regulation of biological quality (GO:0065008) | 1.68 | 12 | TPM1, SCN5A, CASQ2, TRPM4, KCNH2, RYR2, DSG2, TRDN, ANK2, CALM1, DMPK, DSP |
| regulation of heart contraction (GO:0008016) | 4.35 | 12 | RYR2, SCN5A, CASQ2, DSG2, TRPM4, KCNH2, TPM1, TRDN, DMPK, ANK2, CALM1, DSP |
| response to stimulus (GO:0050896) | 1.22 | 11 | TPM1, SCN5A, CASQ2, LMNA, TRPM4, KCNH2, RYR2, DSG2, ANK2, CALM1, DSP |
| regulation of muscle system process (GO:0090257) | 4.51 | 11 | RYR2, SCN5A, CASQ2, TRPM4, TPM1, DSG2, DMPK, ANK2, CALM1, MYBPC3, DSP |
| regulation of muscle contraction (GO:0006937) | 4.75 | 11 | RYR2, SCN5A, CALM1, TRPM4, TPM1, DSG2, DMPK, ANK2, CASQ2, MYBPC3, DSP |
| developmental process (GO:0032502) | 1.36 | 10 | RYR2, CALM1, LMNA, LAMA4, TPM1, DSG2, ANK2, SCN5A, MYBPC3, DSP |
| regulation of membrane potential (GO:0042391) | 3.89 | 10 | RYR2, CASQ2, TRPM4, KCNH2, DSG2, TRDN, ANK2, SCN5A, DMPK, DSP |
| regulation of cellular component movement (GO:0051270) | 3.08 | 10 | RYR2, SCN5A, LMNA, LAMA4, TPM1, DSG2, ANK2, MYBPC3, TRPM4, DSP |
| regulation of transport (GO:0051049) | 2.24 | 10 | RYR2, SCN5A, CASQ2, TRPM4, KCNH2, TRDN, ANK2, CALM1, MYBPC3, DMPK |
| regulation of heart rate (GO:0002027) | 5.29 | 10 | RYR2, SCN5A, CASQ2, TRPM4, KCNH2, TPM1, DSG2, ANK2, CALM1, DSP |
| regulation of striated muscle contraction (GO:0006942) | 5.38 | 10 | RYR2, SCN5A, CALM1, TRPM4, DSG2, DMPK, ANK2, CASQ2, MYBPC3, DSP |
| positive regulation of biological process (GO:0048518) | 1.2 | 10 | RYR2, SCN5A, CASQ2, LMNA, TRPM4, KCNH2, TPM1, TRDN, ANK2, CALM1 |
| localization (GO:0051179) | 1.4 | 10 | RYR2, SCN5A, CASQ2, LMNA, TRPM4, KCNH2, TRDN, ANK2, CALM1, DSP |
| positive regulation of cellular process (GO:0048522) | 1.3 | 10 | RYR2, SCN5A, CASQ2, LMNA, TRPM4, KCNH2, TPM1, TRDN, ANK2, CALM1 |
| transport (GO:0006810) | 1.51 | 9 | RYR2, SCN5A, CASQ2, LMNA, TRPM4, KCNH2, TRDN, ANK2, CALM1 |
| anatomical structure development (GO:0048856) | 1.58 | 9 | TPM1, CALM1, LMNA, LAMA4, RYR2, DSG2, ANK2, SCN5A, DSP |
| cellular component organization (GO:0016043) | 1.24 | 9 | TPM1, CASQ2, DSG2, LAMA4, TRDN, LMNA, DMPK, ANK2, DSP |
| single-organism developmental process (GO:0044767) | 1.49 | 9 | RYR2, CALM1, LMNA, LAMA4, TPM1, ANK2, SCN5A, MYBPC3, DSP |
| response to chemical (GO:0042221) | 1.98 | 9 | RYR2, SCN5A, CALM1, LMNA, KCNH2, TPM1, DSG2, ANK2, CASQ2 |
| establishment of localization (GO:0051234) | 1.48 | 9 | RYR2, SCN5A, CALM1, LMNA, TRPM4, KCNH2, TRDN, ANK2, CASQ2 |
| cellular component organization or biogenesis (GO:0071840) | 1.22 | 9 | TPM1, CASQ2, DSG2, LAMA4, TRDN, LMNA, DMPK, ANK2, DSP |
| system process (GO:0003008) | 2.3 | 9 | RYR2, SCN5A, CASQ2, TRPM4, KCNH2, TPM1, TRDN, CALM1, MYBPC3 |
| single organism signaling (GO:0044700) | 3.25 | 8 | RYR2, CASQ2, TRPM4, KCNH2, DSG2, ANK2, SCN5A, DSP |
| single-multicellular organism process (GO:0044707) | 1.78 | 8 | TPM1, SCN5A, TRPM4, KCNH2, RYR2, DSG2, ANK2, DSP |
| regulation of cellular localization (GO:0060341) | 3.03 | 8 | RYR2, CASQ2, LMNA, TRPM4, TRDN, ANK2, CALM1, MYBPC3 |
| muscle contraction (GO:0006936) | 4.37 | 8 | RYR2, SCN5A, CASQ2, KCNH2, TPM1, TRDN, CALM1, MYBPC3 |
| ion transport (GO:0006811) | 2.66 | 8 | RYR2, SCN5A, CASQ2, TRPM4, KCNH2, TRDN, ANK2, CALM1 |
| regulation of actin filament-based process (GO:0032970) | 3.97 | 8 | TPM1, SCN5A, TRPM4, RYR2, DSG2, ANK2, MYBPC3, DSP |
| regulation of metal ion transport (GO:0010959) | 3.94 | 8 | RYR2, SCN5A, CASQ2, KCNH2, TRDN, ANK2, CALM1, DMPK |
| muscle system process (GO:0003012) | 4.18 | 8 | RYR2, SCN5A, CASQ2, KCNH2, TPM1, TRDN, CALM1, MYBPC3 |
| signaling (GO:0023052) | 3.25 | 8 | RYR2, CASQ2, TRPM4, KCNH2, DSG2, ANK2, SCN5A, DSP |
| regulation of ion transport (GO:0043269) | 3.4 | 8 | RYR2, SCN5A, CASQ2, KCNH2, TRDN, ANK2, CALM1, DMPK |
| regulation of signaling (GO:0023051) | 1.72 | 8 | RYR2, CASQ2, LMNA, TRPM4, TRDN, ANK2, CALM1, DMPK |
| negative regulation of biological process (GO:0048519) | 1.33 | 8 | RYR2, CALM1, TRPM4, KCNH2, TPM1, TRDN, LMNA, CASQ2 |
| regulation of molecular function (GO:0065009) | 1.78 | 8 | RYR2, CALM1, TPM1, TRDN, ANK2, CASQ2, MYBPC3, DMPK |
| regulation of cell communication (GO:0010646) | 1.73 | 8 | RYR2, CASQ2, LMNA, TRPM4, TRDN, ANK2, CALM1, DMPK |
| regulation of cardiac muscle contraction (GO:0055117) | 5.57 | 8 | RYR2, SCN5A, CASQ2, TRPM4, DSG2, ANK2, CALM1, DSP |
| negative regulation of cellular process (GO:0048523) | 1.41 | 8 | RYR2, CASQ2, TRPM4, KCNH2, TPM1, TRDN, LMNA, CALM1 |
| regulation of actin filament-based movement (GO:1903115) | 6.33 | 7 | RYR2, SCN5A, TRPM4, DSG2, ANK2, MYBPC3, DSP |
| regulation of cardiac conduction (GO:1903779) | 5.57 | 7 | RYR2, CASQ2, TRPM4, TRDN, ANK2, CALM1, DMPK |
| positive regulation of transport (GO:0051050) | 2.9 | 7 | RYR2, CALM1, TRPM4, KCNH2, TRDN, ANK2, SCN5A |
| regulation of cation transmembrane transport (GO:1904062) | 4.4 | 7 | RYR2, SCN5A, CALM1, KCNH2, TRDN, ANK2, CASQ2 |
| regulation of homeostatic process (GO:0032844) | 3.65 | 7 | RYR2, SCN5A, CALM1, TRPM4, TRDN, ANK2, CASQ2 |
| ion transmembrane transport (GO:0034220) | 3.08 | 7 | RYR2, CALM1, KCNH2, TRPM4, CASQ2, TRDN, SCN5A |
| regulation of ion homeostasis (GO:2000021) | 4.44 | 7 | RYR2, SCN5A, CASQ2, TRPM4, TRDN, ANK2, CALM1 |
| signal transduction (GO:0007165) | 1.28 | 7 | RYR2, CASQ2, LMNA, KCNH2, ANK2, CALM1, DMPK |
| regulation of ion transmembrane transport (GO:0034765) | 3.77 | 7 | CALM1, RYR2, CASQ2, KCNH2, TRDN, ANK2, SCN5A |
| transmembrane transport (GO:0055085) | 2.72 | 7 | CALM1, RYR2, CASQ2, TRPM4, KCNH2, TRDN, SCN5A |
| regulation of transmembrane transport (GO:0034762) | 3.74 | 7 | RYR2, SCN5A, CALM1, KCNH2, TRDN, ANK2, CASQ2 |
| multicellular organismal signaling (GO:0035637) | 5.36 | 6 | SCN5A, TRPM4, KCNH2, DSG2, ANK2, DSP |
| ion homeostasis (GO:0050801) | 3.42 | 6 | RYR2, TRPM4, KCNH2, TRDN, ANK2, DMPK |
| regulation of response to stimulus (GO:0048583) | 1.54 | 6 | CALM1, TRPM4, TRDN, LMNA, CASQ2, DMPK |
| homeostatic process (GO:0042592) | 2.61 | 6 | RYR2, TRPM4, KCNH2, TRDN, ANK2, DMPK |
| cellular response to chemical stimulus (GO:0070887) | 2.57 | 6 | RYR2, SCN5A, KCNH2, TPM1, LMNA, CASQ2 |
| inorganic ion homeostasis (GO:0098771) | 3.43 | 6 | RYR2, TRPM4, KCNH2, TRDN, ANK2, DMPK |
| intracellular signal transduction (GO:0035556) | 2.39 | 6 | RYR2, CALM1, KCNH2, ANK2, CASQ2, DMPK |
| cardiac muscle contraction (GO:0060048) | 5.88 | 6 | RYR2, CASQ2, KCNH2, TPM1, SCN5A, MYBPC3 |
| regulation of cardiac muscle cell contraction (GO:0086004) | 6.51 | 6 | RYR2, SCN5A, TRPM4, DSG2, ANK2, DSP |
| cellular response to stimulus (GO:0051716) | 1.97 | 6 | RYR2, CASQ2, KCNH2, TPM1, LMNA, SCN5A |
| regulation of signal transduction (GO:0009966) | 1.84 | 6 | CASQ2, TRPM4, TRDN, LMNA, CALM1, DMPK |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 6 | RYR2, SCN5A, TRPM4, TPM1, TRDN, LMNA |
| regulation of action potential (GO:0098900) | 6.07 | 6 | RYR2, SCN5A, TRPM4, DSG2, ANK2, DSP |
| positive regulation of molecular function (GO:0044093) | 2.23 | 6 | RYR2, CALM1, TPM1, TRDN, ANK2, MYBPC3 |
| cardiac conduction (GO:0061337) | 5.54 | 6 | SCN5A, TRPM4, KCNH2, DSG2, ANK2, DSP |
| cation transport (GO:0006812) | 3.11 | 6 | RYR2, SCN5A, TRPM4, KCNH2, TRDN, ANK2 |
| positive regulation of ion transport (GO:0043270) | 4.36 | 6 | RYR2, CALM1, KCNH2, TRDN, ANK2, SCN5A |
| single-organism transport (GO:0044765) | 2.18 | 6 | RYR2, CALM1, LMNA, KCNH2, TRDN, ANK2 |
| metal ion transport (GO:0030001) | 3.36 | 6 | RYR2, SCN5A, TRPM4, KCNH2, TRDN, ANK2 |
| metal ion homeostasis (GO:0055065) | 3.61 | 6 | RYR2, TRPM4, KCNH2, TRDN, ANK2, DMPK |
| cation homeostasis (GO:0055080) | 3.46 | 6 | RYR2, TRPM4, KCNH2, TRDN, ANK2, DMPK |
| single-organism localization (GO:1902578) | 2.09 | 6 | RYR2, CALM1, LMNA, KCNH2, TRDN, ANK2 |
| striated muscle contraction (GO:0006941) | 5.37 | 6 | RYR2, CASQ2, KCNH2, TPM1, SCN5A, MYBPC3 |
| chemical homeostasis (GO:0048878) | 2.97 | 6 | RYR2, TRPM4, KCNH2, TRDN, ANK2, DMPK |
| cellular cation homeostasis (GO:0030003) | 3.6 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| regulation of ion transmembrane transporter activity (GO:0032412) | 4.55 | 5 | CALM1, RYR2, CASQ2, ANK2, TRDN |
| regulation of sequestering of calcium ion (GO:0051282) | 5.07 | 5 | CASQ2, RYR2, CALM1, ANK2, TRDN |
| positive regulation of homeostatic process (GO:0032846) | 4.38 | 5 | CASQ2, TRPM4, CALM1, RYR2, TRDN |
| regulation of calcium ion transmembrane transport (GO:1903169) | 4.98 | 5 | CASQ2, RYR2, CALM1, ANK2, TRDN |
| calcium ion homeostasis (GO:0055074) | 3.97 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| second-messenger-mediated signaling (GO:0019932) | 4.65 | 5 | CALM1, RYR2, CASQ2, DMPK, ANK2 |
| positive regulation of transmembrane transport (GO:0034764) | 4.99 | 5 | CALM1, RYR2, KCNH2, ANK2, TRDN |
| positive regulation of ion transmembrane transport (GO:0034767) | 5.05 | 5 | KCNH2, RYR2, CALM1, ANK2, TRDN |
| divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| cellular protein metabolic process (GO:0044267) | 1.63 | 5 | KCNH2, TRPM4, CALM1, DSP, DMPK |
| anatomical structure morphogenesis (GO:0009653) | 2.53 | 5 | RYR2, SCN5A, MYBPC3, DSP, TPM1 |
| cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| cellular macromolecule metabolic process (GO:0044260) | 0.93 | 5 | CALM1, TRPM4, KCNH2, DSP, DMPK |
| organic substance metabolic process (GO:0071704) | 0.63 | 5 | KCNH2, TRPM4, CALM1, DSP, DMPK |
| single-organism organelle organization (GO:1902589) | 2.68 | 5 | DSP, TPM1, CASQ2, LMNA, TRDN |
| regulation of calcium ion import (GO:0090279) | 5.08 | 5 | CALM1, RYR2, CASQ2, ANK2, TRDN |
| cellular metal ion homeostasis (GO:0006875) | 3.75 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| regulation of transporter activity (GO:0032409) | 4.45 | 5 | CASQ2, RYR2, CALM1, ANK2, TRDN |
| inorganic cation transmembrane transport (GO:0098662) | 3.55 | 5 | KCNH2, TRPM4, SCN5A, RYR2, TRDN |
| regulation of cardiac muscle cell action potential (GO:0098901) | 6.78 | 5 | RYR2, DSP, TRPM4, ANK2, DSG2 |
| regulation of calcium ion transport into cytosol (GO:0010522) | 5.23 | 5 | CALM1, RYR2, CASQ2, ANK2, TRDN |
| cellular homeostasis (GO:0019725) | 3.23 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| calcium-mediated signaling (GO:0019722) | 5.24 | 5 | CALM1, RYR2, CASQ2, DMPK, ANK2 |
| regulation of developmental process (GO:0050793) | 2.1 | 5 | TRPM4, DMPK, LAMA4, LMNA, TPM1 |
| cellular calcium ion homeostasis (GO:0006874) | 4.01 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| regulation of catalytic activity (GO:0050790) | 1.97 | 5 | RYR2, DMPK, CALM1, MYBPC3, TPM1 |
| cellular ion homeostasis (GO:0006873) | 3.57 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| macromolecule modification (GO:0043412) | 1.73 | 5 | KCNH2, TRPM4, CALM1, DSP, DMPK |
| protein modification process (GO:0036211) | 1.79 | 5 | KCNH2, TRPM4, CALM1, DMPK, DSP |
| cellular protein modification process (GO:0006464) | 1.79 | 5 | KCNH2, TRPM4, CALM1, DMPK, DSP |
| metabolic process (GO:0008152) | 0.58 | 5 | CALM1, TRPM4, KCNH2, DSP, DMPK |
| cellular chemical homeostasis (GO:0055082) | 3.4 | 5 | RYR2, TRPM4, DMPK, ANK2, TRDN |
| response to organic substance (GO:0010033) | 2.2 | 5 | CALM1, RYR2, CASQ2, ANK2, DSG2 |
| organelle organization (GO:0006996) | 2.02 | 5 | DSP, TPM1, CASQ2, LMNA, TRDN |
| primary metabolic process (GO:0044238) | 0.69 | 5 | CALM1, TRPM4, KCNH2, DMPK, DSP |
| regulation of calcium ion transmembrane transporter activity (GO:1901019) | 5.49 | 5 | CALM1, RYR2, CASQ2, ANK2, TRDN |
| cytoskeleton organization (GO:0007010) | 3.22 | 5 | DSP, TPM1, CASQ2, LMNA, TRDN |
| protein metabolic process (GO:0019538) | 1.45 | 5 | KCNH2, TRPM4, CALM1, DMPK, DSP |
| regulation of transmembrane transporter activity (GO:0022898) | 4.52 | 5 | CALM1, RYR2, CASQ2, ANK2, TRDN |
| regulation of release of sequestered calcium ion into cytosol (GO:0051279) | 5.44 | 5 | CALM1, RYR2, CASQ2, ANK2, TRDN |
| regulation of calcium ion transport (GO:0051924) | 4.38 | 5 | CASQ2, RYR2, CALM1, ANK2, TRDN |
| inorganic ion transmembrane transport (GO:0098660) | 3.38 | 5 | KCNH2, RYR2, SCN5A, TRPM4, TRDN |
| cellular metabolic process (GO:0044237) | 0.69 | 5 | KCNH2, TRPM4, CALM1, DMPK, DSP |
| macromolecule metabolic process (GO:0043170) | 0.83 | 5 | KCNH2, TRPM4, CALM1, DSP, DMPK |
| regulation of heart rate by cardiac conduction (GO:0086091) | 6.33 | 5 | DSP, KCNH2, SCN5A, ANK2, DSG2 |
| regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.59 | 5 | CASQ2, RYR2, CALM1, ANK2, TRDN |
| cation transmembrane transport (GO:0098655) | 3.43 | 5 | SCN5A, TRPM4, KCNH2, RYR2, TRDN |
| positive regulation of cation transmembrane transport (GO:1904064) | 5.17 | 5 | KCNH2, RYR2, CALM1, ANK2, TRDN |
| positive regulation of ion transmembrane transporter activity (GO:0032414) | 5.55 | 4 | RYR2, CALM1, ANK2, TRDN |
| positive regulation of transporter activity (GO:0032411) | 5.44 | 4 | RYR2, CALM1, ANK2, TRDN |
| ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 6.07 | 4 | DSP, RYR2, MYBPC3, TPM1 |
| membrane organization (GO:0061024) | 3.04 | 4 | DMPK, ANK2, LMNA, TRDN |
| negative regulation of response to stimulus (GO:0048585) | 2.52 | 4 | CASQ2, CALM1, LMNA, TRDN |
| regulation of membrane repolarization (GO:0060306) | 6.4 | 4 | CASQ2, SCN5A, ANK2, KCNH2 |
| negative regulation of homeostatic process (GO:0032845) | 4.91 | 4 | CASQ2, RYR2, CALM1, TRDN |
| negative regulation of signaling (GO:0023057) | 2.65 | 4 | CASQ2, CALM1, LMNA, TRDN |
| negative regulation of cell communication (GO:0010648) | 2.66 | 4 | CALM1, CASQ2, LMNA, TRDN |
| cell communication (GO:0007154) | 3.04 | 4 | SCN5A, RYR2, CASQ2, ANK2 |
| action potential (GO:0001508) | 5.42 | 4 | KCNH2, RYR2, SCN5A, ANK2 |
| negative regulation of ion transmembrane transport (GO:0034766) | 5.47 | 4 | KCNH2, CASQ2, CALM1, TRDN |
| cell communication involved in cardiac conduction (GO:0086065) | 6.73 | 4 | SCN5A, RYR2, CASQ2, ANK2 |
| response to organic cyclic compound (GO:0014070) | 3.07 | 4 | CASQ2, RYR2, CALM1, DSG2 |
| negative regulation of transmembrane transport (GO:0034763) | 5.38 | 4 | CASQ2, CALM1, TRDN, KCNH2 |
| response to endogenous stimulus (GO:0009719) | 2.79 | 4 | CASQ2, RYR2, CALM1, DSG2 |
| ventricular cardiac muscle cell action potential (GO:0086005) | 7.02 | 4 | SCN5A, RYR2, KCNH2, ANK2 |
| cardiac muscle cell action potential involved in contraction (GO:0086002) | 6.47 | 4 | KCNH2, RYR2, SCN5A, ANK2 |
| cardiac muscle cell action potential (GO:0086001) | 6.33 | 4 | KCNH2, RYR2, SCN5A, ANK2 |
| positive regulation of hydrolase activity (GO:0051345) | 2.91 | 4 | RYR2, CALM1, MYBPC3, TPM1 |
| positive regulation of blood circulation (GO:1903524) | 5.16 | 4 | TRPM4, SCN5A, RYR2, TPM1 |
| positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 6.36 | 4 | RYR2, CALM1, ANK2, TRDN |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 4 | RYR2, CALM1, MYBPC3, TPM1 |
| tissue morphogenesis (GO:0048729) | 3.87 | 4 | DSP, RYR2, MYBPC3, TPM1 |
| positive regulation of calcium ion transmembrane transport (GO:1904427) | 5.69 | 4 | RYR2, CALM1, ANK2, TRDN |
| biological adhesion (GO:0022610) | 2.81 | 4 | DSP, LAMA4, MYBPC3, DSG2 |
| positive regulation of sequestering of calcium ion (GO:0051284) | 7.09 | 4 | CASQ2, RYR2, CALM1, TRDN |
| positive regulation of heart rate (GO:0010460) | 6.59 | 4 | TRPM4, SCN5A, RYR2, TPM1 |
| regulation of hydrolase activity (GO:0051336) | 2.53 | 4 | RYR2, CALM1, MYBPC3, TPM1 |
| negative regulation of transport (GO:0051051) | 3.6 | 4 | CASQ2, CALM1, TRDN, KCNH2 |
| cardiac muscle tissue morphogenesis (GO:0055008) | 5.8 | 4 | RYR2, MYBPC3, DSP, TPM1 |
| calcium ion transport (GO:0006816) | 4.33 | 4 | RYR2, TRPM4, ANK2, TRDN |
| response to calcium ion (GO:0051592) | 4.98 | 4 | CASQ2, RYR2, SCN5A, CALM1 |
| negative regulation of ion transport (GO:0043271) | 4.94 | 4 | CALM1, KCNH2, CASQ2, TRDN |
| response to stress (GO:0006950) | 1.8 | 4 | RYR2, DSP, LMNA, TPM1 |
| single-organism membrane organization (GO:0044802) | 3.19 | 4 | DMPK, ANK2, LMNA, TRDN |
| response to metal ion (GO:0010038) | 3.91 | 4 | CASQ2, RYR2, SCN5A, CALM1 |
| establishment of localization in cell (GO:0051649) | 2.47 | 4 | RYR2, ANK2, TRDN, LMNA |
| cell adhesion (GO:0007155) | 2.82 | 4 | DSP, LAMA4, MYBPC3, DSG2 |
| divalent metal ion transport (GO:0070838) | 4.15 | 4 | RYR2, TRPM4, ANK2, TRDN |
| response to inorganic substance (GO:0010035) | 3.56 | 4 | CALM1, RYR2, SCN5A, CASQ2 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 4 | RYR2, CALM1, TPM1, DSG2 |
| divalent inorganic cation transport (GO:0072511) | 4.13 | 4 | RYR2, TRPM4, ANK2, TRDN |
| negative regulation of signal transduction (GO:0009968) | 2.75 | 4 | CALM1, CASQ2, LMNA, TRDN |
| positive regulation of calcium ion transport (GO:0051928) | 5.06 | 4 | RYR2, CALM1, ANK2, TRDN |
| negative regulation of cation transmembrane transport (GO:1904063) | 5.65 | 4 | CASQ2, CALM1, TRDN, KCNH2 |
| positive regulation of heart contraction (GO:0045823) | 6.15 | 4 | TRPM4, SCN5A, RYR2, TPM1 |
| regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.68 | 4 | CALM1, RYR2, CASQ2, ANK2 |
| regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881) | 6.9 | 4 | CALM1, RYR2, CASQ2, ANK2 |
| regulation of cation channel activity (GO:2001257) | 5.27 | 4 | CASQ2, CALM1, ANK2, TRDN |
| muscle tissue morphogenesis (GO:0060415) | 5.62 | 4 | DSP, RYR2, MYBPC3, TPM1 |
| regulation of ventricular cardiac muscle cell action potential (GO:0098911) | 7.33 | 3 | RYR2, DSP, DSG2 |
| protein localization (GO:0008104) | 2.36 | 3 | DSP, LMNA, ANK2 |
| negative regulation of transporter activity (GO:0032410) | 5.59 | 3 | CASQ2, CALM1, TRDN |
| regulation of metabolic process (GO:0019222) | 1.02 | 3 | RYR2, CALM1, ANK2 |
| negative regulation of ion transmembrane transporter activity (GO:0032413) | 5.74 | 3 | CASQ2, CALM1, TRDN |
| phosphorylation (GO:0016310) | 2.63 | 3 | CALM1, KCNH2, DMPK |
| cell junction organization (GO:0034330) | 4.51 | 3 | DSP, ANK2, DSG2 |
| regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 6.84 | 3 | KCNH2, SCN5A, ANK2 |
| negative regulation of calcium-mediated signaling (GO:0050849) | 6.9 | 3 | CASQ2, CALM1, TRDN |
| regulation of calcium-mediated signaling (GO:0050848) | 5.41 | 3 | CASQ2, CALM1, TRDN |
| positive regulation of signaling (GO:0023056) | 2.41 | 3 | TRPM4, CALM1, TRDN |
| regulation of potassium ion transport (GO:0043266) | 5.31 | 3 | KCNH2, CASQ2, ANK2 |
| membrane depolarization (GO:0051899) | 5.62 | 3 | KCNH2, SCN5A, ANK2 |
| regulation of cell migration (GO:0030334) | 3.23 | 3 | LAMA4, TPM1, LMNA |
| regulation of cell communication by electrical coupling (GO:0010649) | 7.33 | 3 | CALM1, CASQ2, TRDN |
| detection of chemical stimulus (GO:0009593) | 3.49 | 3 | CASQ2, RYR2, CALM1 |
| positive regulation of cell communication (GO:0010647) | 2.41 | 3 | TRPM4, CALM1, TRDN |
| regulation of intracellular signal transduction (GO:1902531) | 2.31 | 3 | CASQ2, CALM1, TRDN |
| negative regulation of calcium ion import (GO:0090281) | 6.59 | 3 | CASQ2, CALM1, TRDN |
| negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 6.59 | 3 | CALM1, CASQ2, TRDN |
| positive regulation of signal transduction (GO:0009967) | 2.5 | 3 | TRPM4, CALM1, TRDN |
| movement of cell or subcellular component (GO:0006928) | 2.61 | 3 | TRPM4, MYBPC3, TPM1 |
| sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.33 | 3 | RYR2, ANK2, TRDN |
| cellular developmental process (GO:0048869) | 1.82 | 3 | LAMA4, DSP, LMNA |
| negative regulation of molecular function (GO:0044092) | 2.74 | 3 | CALM1, CASQ2, TRDN |
| regulation of cell motility (GO:2000145) | 3.16 | 3 | LAMA4, TPM1, LMNA |
| macromolecule localization (GO:0033036) | 2.34 | 3 | DSP, LMNA, ANK2 |
| regulation of receptor activity (GO:0010469) | 4.98 | 3 | CALM1, CASQ2, TRDN |
| monovalent inorganic cation transport (GO:0015672) | 3.74 | 3 | KCNH2, TRPM4, SCN5A |
| negative regulation of calcium ion transport into cytosol (GO:0010523) | 6.9 | 3 | CASQ2, CALM1, TRDN |
| regulation of cell proliferation (GO:0042127) | 2.41 | 3 | TRPM4, SCN5A, TPM1 |
| negative regulation of receptor activity (GO:2000272) | 6.4 | 3 | CASQ2, CALM1, TRDN |
| protein phosphorylation (GO:0006468) | 2.89 | 3 | KCNH2, CALM1, DMPK |
| positive regulation of response to stimulus (GO:0048584) | 2.18 | 3 | TRPM4, CALM1, TRDN |
| negative regulation of calcium ion transmembrane transport (GO:1903170) | 6.43 | 3 | CALM1, CASQ2, TRDN |
| actin filament-based process (GO:0030029) | 3.94 | 3 | MYBPC3, CASQ2, TPM1 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 3 | RYR2, CALM1, ANK2 |
| positive regulation of ATPase activity (GO:0032781) | 5.99 | 3 | RYR2, MYBPC3, TPM1 |
| positive regulation of cation channel activity (GO:2001259) | 6.17 | 3 | CALM1, ANK2, TRDN |
| establishment of protein localization (GO:0045184) | 2.53 | 3 | RYR2, ANK2, LMNA |
| negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 7.43 | 3 | CASQ2, CALM1, TRDN |
| regulation of cell differentiation (GO:0045595) | 2.42 | 3 | TRPM4, DMPK, LMNA |
| regulation of ATPase activity (GO:0043462) | 5.59 | 3 | RYR2, MYBPC3, TPM1 |
| regulation of potassium ion transmembrane transport (GO:1901379) | 5.62 | 3 | KCNH2, CASQ2, ANK2 |
| negative regulation of release of sequestered calcium ion into cytosol (GO:0051280) | 7.16 | 3 | CALM1, CASQ2, TRDN |
| cell-cell junction organization (GO:0045216) | 4.66 | 3 | DSP, ANK2, DSG2 |
| negative regulation of intracellular signal transduction (GO:1902532) | 3.63 | 3 | CASQ2, CALM1, TRDN |
| membrane depolarization during action potential (GO:0086010) | 6.07 | 3 | KCNH2, SCN5A, ANK2 |
| regulation of cellular component organization (GO:0051128) | 2.01 | 3 | TPM1, DMPK, LMNA |
| regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 6.51 | 3 | CALM1, CASQ2, TRDN |
| regulation of locomotion (GO:0040012) | 3.12 | 3 | LAMA4, TPM1, LMNA |
| detection of stimulus (GO:0051606) | 3.22 | 3 | CALM1, RYR2, CASQ2 |
| regulation of cytosolic calcium ion concentration (GO:0051480) | 4.41 | 3 | TRPM4, RYR2, TRDN |
| negative regulation of calcium ion transport (GO:0051926) | 5.84 | 3 | CALM1, CASQ2, TRDN |
| response to organonitrogen compound (GO:0010243) | 3.2 | 3 | CASQ2, RYR2, CALM1 |
| calcium ion transmembrane transport (GO:0070588) | 4.67 | 3 | TRPM4, RYR2, TRDN |
| positive regulation of cytosolic calcium ion concentration (GO:0007204) | 4.56 | 3 | TRPM4, RYR2, TRDN |
| detection of calcium ion (GO:0005513) | 7.24 | 3 | CALM1, RYR2, CASQ2 |
| phosphate-containing compound metabolic process (GO:0006796) | 2.16 | 3 | KCNH2, CALM1, DMPK |
| regulation of cardiac muscle cell membrane repolarization (GO:0099623) | 6.68 | 3 | KCNH2, SCN5A, ANK2 |
| regulation of multicellular organismal development (GO:2000026) | 2.31 | 3 | TRPM4, LAMA4, LMNA |
| regulation of atrial cardiac muscle cell action potential (GO:0098910) | 8.12 | 3 | TRPM4, RYR2, ANK2 |
| negative regulation of cation channel activity (GO:2001258) | 6.26 | 3 | CALM1, CASQ2, TRDN |
| phosphorus metabolic process (GO:0006793) | 2.15 | 3 | KCNH2, CALM1, DMPK |
| response to nitrogen compound (GO:1901698) | 3.12 | 3 | CALM1, RYR2, CASQ2 |
| heterotypic cell-cell adhesion (GO:0034113) | 6.43 | 2 | DSP, DSG2 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 2 | RYR2, CALM1 |
| negative regulation of sequestering of calcium ion (GO:0051283) | 6.04 | 2 | RYR2, TRDN |
| positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 6.12 | 2 | CALM1, TRDN |
| cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042) | 7.94 | 2 | DSP, DSG2 |
| circulatory system process (GO:0003013) | 4.38 | 2 | TRPM4, TRDN |
| cell surface receptor signaling pathway (GO:0007166) | 2.09 | 2 | RYR2, CALM1 |
| membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 7.09 | 2 | SCN5A, ANK2 |
| cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114) | 3.79 | 2 | RYR2, CALM1 |
| signal transduction by protein phosphorylation (GO:0023014) | 3.79 | 2 | KCNH2, CALM1 |
| single-organism metabolic process (GO:0044710) | 1.63 | 2 | KCNH2, CALM1 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | CALM1, ANK2 |
| cellular macromolecule localization (GO:0070727) | 3.1 | 2 | LMNA, ANK2 |
| cellular response to organic substance (GO:0071310) | 2.78 | 2 | RYR2, CASQ2 |
| response to mechanical stimulus (GO:0009612) | 4.41 | 2 | RYR2, LMNA |
| release of sequestered calcium ion into cytosol (GO:0051209) | 6.04 | 2 | RYR2, TRDN |
| regulation of SA node cell action potential (GO:0098907) | 9.04 | 2 | RYR2, ANK2 |
| regulation of osteoblast differentiation (GO:0045667) | 4.99 | 2 | TRPM4, LMNA |
| animal organ development (GO:0048513) | 2.53 | 2 | DSP, LMNA |
| positive regulation of calcium ion transport into cytosol (GO:0010524) | 5.82 | 2 | CALM1, TRDN |
| positive regulation of cardiac conduction (GO:1903781) | 8.63 | 2 | TRPM4, TRDN |
| muscle filament sliding (GO:0030049) | 6.09 | 2 | MYBPC3, TPM1 |
| actin filament-based movement (GO:0030048) | 5.54 | 2 | MYBPC3, TPM1 |
| positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.78 | 2 | CALM1, TRDN |
| calcium ion import into cytosol (GO:1902656) | 5.99 | 2 | RYR2, TRDN |
| desmosome organization (GO:0002934) | 7.53 | 2 | DSP, DSG2 |
| single organism reproductive process (GO:0044702) | 2.73 | 2 | LMNA, DSG2 |
| vesicle-mediated transport (GO:0016192) | 2.72 | 2 | CALM1, ANK2 |
| response to external stimulus (GO:0009605) | 2.55 | 2 | RYR2, LMNA |
| Wnt signaling pathway (GO:0016055) | 3.88 | 2 | RYR2, CALM1 |
| regulation of gene expression (GO:0010468) | 1.37 | 2 | RYR2, ANK2 |
| calcium ion import (GO:0070509) | 5.57 | 2 | RYR2, TRDN |
| cellular response to stress (GO:0033554) | 2.51 | 2 | TPM1, LMNA |
| response to hormone (GO:0009725) | 3.33 | 2 | CALM1, DSG2 |
| cellular component assembly (GO:0022607) | 2.14 | 2 | CASQ2, ANK2 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 2 | CALM1, ANK2 |
| microtubule cytoskeleton organization (GO:0000226) | 4.13 | 2 | LMNA, TRDN |
| intracellular protein transport (GO:0006886) | 3.2 | 2 | LMNA, ANK2 |
| Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029) | 9.04 | 2 | RYR2, CASQ2 |
| regulation of immune system process (GO:0002682) | 2.5 | 2 | TRPM4, CALM1 |
| cellular protein localization (GO:0034613) | 3.11 | 2 | LMNA, ANK2 |
| calcium ion transmembrane import into cytosol (GO:0097553) | 5.99 | 2 | RYR2, TRDN |
| positive regulation of receptor activity (GO:2000273) | 5.97 | 2 | CALM1, TRDN |
| organ morphogenesis (GO:0009887) | 3.55 | 2 | MYBPC3, SCN5A |
| single organism cell adhesion (GO:0098602) | 3.63 | 2 | DSP, DSG2 |
| cell-cell adhesion (GO:0098609) | 3.34 | 2 | DSP, DSG2 |
| release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808) | 7.78 | 2 | RYR2, TRDN |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 2 | RYR2, CALM1 |
| tissue development (GO:0009888) | 3.27 | 2 | DSP, DSG2 |
| response to caffeine (GO:0031000) | 6.84 | 2 | RYR2, CASQ2 |
| sodium ion transport (GO:0006814) | 4.75 | 2 | TRPM4, SCN5A |
| programmed cell death (GO:0012501) | 3.1 | 2 | RYR2, DMPK |
| wound healing (GO:0042060) | 5.13 | 2 | TPM1, DSP |
| positive regulation of intracellular signal transduction (GO:1902533) | 2.95 | 2 | CALM1, TRDN |
| regulation of ossification (GO:0030278) | 4.53 | 2 | TRPM4, LMNA |
| regulation of heart rate by chemical signal (GO:0003062) | 8.12 | 2 | TPM1, KCNH2 |
| intracellular transport (GO:0046907) | 2.67 | 2 | ANK2, LMNA |
| response to decreased oxygen levels (GO:0036293) | 4.09 | 2 | RYR2, LMNA |
| cellular response to nitrogen compound (GO:1901699) | 3.79 | 2 | RYR2, CASQ2 |
| regulation of organelle organization (GO:0033043) | 2.72 | 2 | TPM1, LMNA |
| regulation of cell adhesion (GO:0030155) | 3.27 | 2 | LAMA4, TPM1 |
| cell differentiation (GO:0030154) | 2.14 | 2 | LAMA4, DSP |
| response to wounding (GO:0009611) | 4.39 | 2 | TPM1, DSP |
| peptidyl-amino acid modification (GO:0018193) | 2.98 | 2 | TRPM4, DMPK |
| response to purine-containing compound (GO:0014074) | 4.67 | 2 | RYR2, CASQ2 |
| response to hypoxia (GO:0001666) | 4.13 | 2 | RYR2, LMNA |
| regulation of protein localization (GO:0032880) | 2.88 | 2 | TRPM4, LMNA |
| positive regulation of calcium ion import (GO:0090280) | 5.72 | 2 | CALM1, TRDN |
| membrane depolarization during SA node cell action potential (GO:0086046) | 8.34 | 2 | SCN5A, ANK2 |
| negative regulation of multicellular organismal process (GO:0051241) | 2.84 | 2 | TRPM4, LMNA |
| actin-myosin filament sliding (GO:0033275) | 6.09 | 2 | MYBPC3, TPM1 |
| cellular localization (GO:0051641) | 2.32 | 2 | LMNA, ANK2 |
| regulation of sodium ion transport (GO:0002028) | 5.4 | 2 | SCN5A, DMPK |
| positive regulation of cell proliferation (GO:0008284) | 3.01 | 2 | TRPM4, SCN5A |
| multicellular organismal reproductive process (GO:0048609) | 3.35 | 2 | LMNA, DSG2 |
| response to abiotic stimulus (GO:0009628) | 2.8 | 2 | RYR2, LMNA |
| establishment of protein localization to organelle (GO:0072594) | 3.92 | 2 | RYR2, LMNA |
| positive regulation of cell differentiation (GO:0045597) | 3.01 | 2 | TRPM4, LMNA |
| cell-cell signaling involved in cardiac conduction (GO:0086019) | 8.12 | 2 | RYR2, CASQ2 |
| sarcomere organization (GO:0045214) | 6.4 | 2 | TPM1, CASQ2 |
| mitotic cell cycle process (GO:1903047) | 3.12 | 2 | CALM1, LMNA |
| response to alkaloid (GO:0043279) | 4.83 | 2 | RYR2, CASQ2 |
| SA node cell action potential (GO:0086015) | 7.94 | 2 | SCN5A, ANK2 |
| negative regulation of developmental process (GO:0051093) | 3.17 | 2 | TRPM4, LMNA |
| regulation of immune response (GO:0050776) | 2.98 | 2 | TRPM4, CALM1 |
| positive regulation of developmental process (GO:0051094) | 2.77 | 2 | TRPM4, LMNA |
| cellular response to organic cyclic compound (GO:0071407) | 3.93 | 2 | RYR2, CASQ2 |
| regulation of membrane depolarization (GO:0003254) | 6.04 | 2 | TRPM4, SCN5A |
| protein localization to organelle (GO:0033365) | 3.57 | 2 | LMNA, ANK2 |
| response to steroid hormone (GO:0048545) | 4.24 | 2 | CALM1, DSG2 |
| cellular response to endogenous stimulus (GO:0071495) | 3.33 | 2 | RYR2, CASQ2 |
| single organismal cell-cell adhesion (GO:0016337) | 3.69 | 2 | DSP, DSG2 |
| actomyosin structure organization (GO:0031032) | 5.4 | 2 | TPM1, CASQ2 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 2 | RYR2, CALM1 |
| calcium ion transport from endoplasmic reticulum to cytosol (GO:1903514) | 7.78 | 2 | RYR2, TRDN |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 2 | RYR2, CALM1 |
| actin cytoskeleton organization (GO:0030036) | 4.1 | 2 | TPM1, CASQ2 |
| negative regulation of potassium ion transport (GO:0043267) | 6.26 | 2 | KCNH2, CASQ2 |
| cell cycle process (GO:0022402) | 2.75 | 2 | CALM1, LMNA |
| regulation of potassium ion transmembrane transporter activity (GO:1901016) | 6.02 | 2 | CASQ2, ANK2 |
| Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068) | 9.04 | 2 | RYR2, CASQ2 |
| cell death (GO:0008219) | 3.05 | 2 | RYR2, DMPK |
| multicellular organism development (GO:0007275) | 2.54 | 2 | RYR2, TPM1 |
| positive regulation of potassium ion transport (GO:0043268) | 6.09 | 2 | KCNH2, ANK2 |
| positive regulation of action potential (GO:0045760) | 7.33 | 2 | TRPM4, SCN5A |
| response to lipid (GO:0033993) | 3.11 | 2 | CALM1, DSG2 |
| cellular response to organonitrogen compound (GO:0071417) | 3.87 | 2 | RYR2, CASQ2 |
| cellular response to alkaloid (GO:0071312) | 6.2 | 2 | RYR2, CASQ2 |
| cellular response to caffeine (GO:0071313) | 7.65 | 2 | RYR2, CASQ2 |
| sodium ion transmembrane transport (GO:0035725) | 5.23 | 2 | TRPM4, SCN5A |
| regulation of adipose tissue development (GO:1904177) | 8.63 | 2 | TRPM4, LMNA |
| organic substance transport (GO:0071702) | 2.15 | 2 | ANK2, LMNA |
| negative regulation of potassium ion transmembrane transport (GO:1901380) | 6.68 | 2 | CASQ2, KCNH2 |
| positive regulation of potassium ion transmembrane transport (GO:1901381) | 6.43 | 2 | KCNH2, ANK2 |
| regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844) | 7.78 | 2 | CALM1, TRDN |
| positive regulation of calcium-mediated signaling (GO:0050850) | 6.12 | 2 | CALM1, TRDN |
| cytosolic calcium ion transport (GO:0060401) | 5.74 | 2 | RYR2, TRDN |
| calcium ion transport into cytosol (GO:0060402) | 5.78 | 2 | RYR2, TRDN |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 2 | RYR2, CALM1 |
| homotypic cell-cell adhesion (GO:0034109) | 5.76 | 2 | DSP, DSG2 |
| apoptotic process (GO:0006915) | 3.14 | 2 | RYR2, DMPK |
| reproductive process (GO:0022414) | 2.55 | 2 | LMNA, DSG2 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 2 | RYR2, CALM1 |
| cell-cell signaling (GO:0007267) | 3.35 | 2 | RYR2, CASQ2 |
| bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073) | 7.94 | 2 | DSP, DSG2 |
| response to oxygen levels (GO:0070482) | 4.02 | 2 | RYR2, LMNA |
| cellular response to oxygen-containing compound (GO:1901701) | 3.22 | 2 | RYR2, TPM1 |
| microtubule-based process (GO:0007017) | 3.54 | 2 | LMNA, TRDN |
| nuclear envelope organization (GO:0006998) | 5.45 | 2 | DMPK, LMNA |
| cellular response to purine-containing compound (GO:0071415) | 7.53 | 2 | RYR2, CASQ2 |
| response to ketone (GO:1901654) | 4.53 | 2 | CALM1, DSG2 |
| protein transport (GO:0015031) | 2.62 | 2 | ANK2, LMNA |
| single-organism intracellular transport (GO:1902582) | 3.59 | 2 | ANK2, LMNA |
| actin-mediated cell contraction (GO:0070252) | 5.88 | 2 | MYBPC3, TPM1 |
| single-organism cellular localization (GO:1902580) | 3.16 | 2 | LMNA, ANK2 |